Sign in
Download Opera News App

Health-COVID

Novavax begins phase three trial of COVID-19 vaccine in the US

Novavax begins phase three trial of COVID-19 vaccine in the US

US biotech company Novavax has begun phase three trials of its COVID-19 vaccine in the US and Mexico. This is reported on the website of the US National Institutes of Health (NIH). The randomized placebo-controlled trial of the NVX-CoV2373 candidate vaccine developed by Novavax Inc. will involve about 30,000 people from 115 medical centers. During the tests, scientists will evaluate the safety and...

Read Full Story
NIAID NIH Novavax Office of Advanced Biomedical Research and Development US US National Institutes of Health